Atlas Private Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Atlas Private Wealth Advisors's PFE Position: Q3 2025 in Review
Atlas Private Wealth Advisors sold out of Pfizer (PFE) in Q3 2025, closing a stake of 17,149 shares — an estimated $416K sold.
Atlas Private Wealth Advisors first reported a position in PFE in Q2 2020 and held it in 21 quarters. The position peaked at $1.95M in Q2 2023. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Atlas Private Wealth Advisors reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Atlas Private Wealth Advisors sold 17,149 Pfizer shares in Q3 2025, an estimated $416K.
- Atlas Private Wealth Advisors first reported a position in Pfizer in Q2 2020 and held it in 21 quarters.
- Atlas Private Wealth Advisors's Pfizer position peaked at $1.95M in Q2 2023.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Atlas Private Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.